<?xml version="1.0" encoding="utf-8"?>
<export-example>
  <doc>
    <id>1294</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>deu</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>72</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-02-24</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2022-01-06</thesisDateAccepted>
    <title language="deu">Chancen und Risiken einer CRISPR/Cas9 basierten Gentherapie an Duchenne Muskel Dystrophie und Zystischer Fibrose</title>
    <abstract language="deu">Hintergrund: Seit 2013 gewinnt das autonome Immunsystem der Bakterien CRISPR/Cas9 an Bedeutung für die Humanmedizin. Das System kann einen präzisen Schnitt in der DNA verursachen, gegebenenfalls neue Gene einsetzen. Mit CRISPR/Cas9 könnten krankheitsverursachende Gene potenziell ausgeschaltet und eine phänotypische Verbesserung oder Heilung ermöglicht werden. Jedoch gibt es noch Herausforderungen, welche die Behandlungsmöglichkeiten in der konventionellen Humanmedizin limitieren. Ziel der Arbeit: Ziel dieser Arbeit ist eine Abhandlung über die Chancen, Risiken und Herausforderungen der Genschere CRISPR/Cas9 in der Humanmedizin an genetisch bedingten Erkrankungen am Beispiel von Duchenne Muskel Dystrophie und Zystischer Fibrose.&#13;
&#13;
Ergebnisse: CRISPR/Cas9 kann an CF humanisierten Säugetiermodellen, sowie IPS Stammzellen eine Korrektur der F508 Deletion im CFTR Gen verursachen. Die Forskolin Schwellung ist nach Behandlung mit CRIPSR/Cas9 im Säugetiermodell wiederhergestellt. Es trat ein Off-Target Effekt auf. Gleichwohl konnte eine Behandlung mit CRISPR/Cas9 am humanisierten Säugetiermodell für DMD die Dystrophin-Expression wiederherstellen. Muskelkraft in Skelett- und Herzmuskulatur hat sich signifikant verbessert. Es kam zu On-Target Effekten und Immunreaktionen. &#13;
&#13;
Fazit: CRISPR/Cas9 hat das Potenzial genetische Mutationen zu korrigieren und die Gen-Expression zu retten. Weitere Studien müssen unternommen werden, um das Risiko von Off-Target Effekten zu minimieren, Langzeitwirkungen zu beobachten und Drug Delivery zu optimieren.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-12940</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <licence>Bestimmungen des deutschen Urheberrechts</licence>
    <author>Priscilla Wujec</author>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>CRISPR/Cas9</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>CRISPR</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Cas9</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Gentherapie</value>
    </subject>
    <collection role="ddc" number="50">Naturwissenschaften</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1294/Wujec_Priscilla_Bachelorarbeit.pdf</file>
  </doc>
  <doc>
    <id>1532</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>83</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-06-30</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2022-04-18</thesisDateAccepted>
    <title language="eng">Significance of gut microbiota in prognosis of cancer therapy-induced rectal mucositis and treatment outcome</title>
    <abstract language="eng">Colorectal cancer is a common type of cancer. Chemotherapy is an important method to treat cancer. 5-fluorouracil (5-FU) is a commonly used drug in chemotherapy regimens. 5-FU not only inhibited cancer cell division but also accelerated the apoptosis of intestinal epithelial cells. lead to colorectal mucositis. Some patients will develop severe mucositis, making subsequent treatment difficult and even life-threatening. The role of gut microbiota in the process of 5-FU-induced colorectal mucositis, and the regulation of gut microbiota through dietary regimens to reduce the possibility of colorectal mucositis deterioration are the research directions of this thesis. This thesis uses PubMed, NCBI and textbooks as the main reference sources, and some information comes from trusted websites. Through review and integration of research, it was concluded that gut microbiota played a non-negligible role in 5-FU-induced colorectal mucositis. Probiotics help maintain the stability of the intestinal mucosal barrier. The main cause of colorectal mucositis is that 5-FU suppresses the immune system and disrupts the immune system. Under the influence of 5-FU, intestinal flora dysbiosis occurs, and the intestinal mucosal barrier function is negatively affected. This leads to the worsening of colorectal mucositis. It can be inferred from research that a reasonable dietary regimen can reduce the possibility of exacerbation of colorectal mucositis. Furthermore, the digestive tract should be viewed as a whole. The role of the stomach and small intestine in the process of 5-FU-induced colorectal mucositis still needs further study. The research of gut microbes in this thesis focuses on Bifidobacterium and Lactobacillus. Pathogenic/opportunistic pathogens and other probiotics are understudied. More in-depth studies are still needed on the role of gut microbes in the process of 5-FU-induced colorectal mucositis</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-15323</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY 4.0 International - Namensnennung</licence>
    <author>Ziang Wu</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Colorectal mucositis</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Micobiota</value>
    </subject>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1532/Wu_Bioengineering.pdf</file>
  </doc>
  <doc>
    <id>201</id>
    <completedYear/>
    <publishedYear>2018</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2018-02-26</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2018-01-22</thesisDateAccepted>
    <title language="eng">Selectivity and Sensitivity Based Emission Line  Table for Analysis of Typical, Environmentally  Relevant Matrices by Inductively Coupled Plasma-Optical Emission Spectrometry (ICP-OES)</title>
    <abstract language="eng">The thesis presents the development of a method which can be used for the easy and accurate selection of suitable emission lines for the analysis of specific elements in soil samples. In the formation of line spectra, line broadening, e.g. Doppler broadening and natural line broadening, might occur causing asymmetric line shape and emission lines´ overlap from various elements. Frequently, the emission line of the element of interest is in close proximity or even overlap-ping with the emission lines from other elements.&#13;
&#13;
Two classification tables were developed during this thesis: the emission line table and the interference table. The emission line table serves as the first step in identifying possible emis-sion lines of an element according to their sensitivity. The interference table was created for each emission line listed in the aforementioned table to highlight possible interferences caused by other elements present in the soil sample. In addition to the classification tables, a procedure flow chart was designed as a guideline for users to ensure proper use of elaborated tables during soil sample analysis.&#13;
&#13;
Results obtained from the filtering method such as full width at half maximum (FWHM) and symmetry using area comparison proves to be suitable even for Doppler broadening. Identifica-tion of possible interference to a certain distance was decided empirically through emission line graphs comparison while using the FWHM as a factor for the distance range. A threshold of sensitivity difference between the element of interest and possible interfering elements was also established based on an assumption of 10% interference for each distance range.&#13;
&#13;
Tables and flow chart presented in this thesis prove the feasibility of the elaborated method in identifying suitable emission lines for an element during soil sample analysis. Further studies should be performed to test (re)producibility of obtained data.</abstract>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Chui Yi Wong</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
  </doc>
  <doc>
    <id>1673</id>
    <completedYear/>
    <publishedYear>2023</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>80</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2023-02-06</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2022-12-27</thesisDateAccepted>
    <title language="eng">Evaluating the potential of mRNA vaccines for human rabies</title>
    <abstract language="eng">To this date, rabies is still one of the most fatal diseases worldwide and generates at least 59,000 deaths per year. Although current vaccines are safe and effective, RNA technology proposes improved vaccines that are potentially able to facilitate eradication of rabies until 2030. In this review, RNA vaccine candidates are evaluated for their potential to be effective against rabies and to be implemented in immunization programs. To understand the relevance of disease prevention, rabies virus and its function in the body is clarified. RNA technology is explained to comprehend its mode of action in the human immune system and its potential to be a vaccine platform. Comparison to existing vaccines showed advantages in several characteristics that are relevant for vaccine approval. RNA vaccines scored better in efficacy, stability, production, and dosing, but there is still room for improvements in terms of safety and tolerability. Theoretical potential is proven, but practical translation of RNA vaccines into clinical candidates requires more attention, as safety and tolerability are the leading limiting factor for approval of any new drug or vaccine. Producing a safe, stable and effective RNA vaccine does not necessarily ensure less rabies deaths, because rabies control strategies heavily rely on proper funding and availability in these rabies endemic region. Nonetheless, RNA vaccine technology offers potential solutions for the elimination of rabies.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-16737</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>Bestimmungen des deutschen Urheberrechts</licence>
    <author>Ole Waller</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1673/Bachelorthesis_OWaller_25337.pdf</file>
  </doc>
  <doc>
    <id>2034</id>
    <completedYear/>
    <publishedYear>2024</publishedYear>
    <thesisYearAccepted/>
    <language>deu</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>80</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2024-09-06</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2024-07-15</thesisDateAccepted>
    <title language="deu">Über die antidepressiven Effekte sportlicher Aktivität: Eine Metaanalyse klinischer Studien zu potenziellen Wirkmechanismen</title>
    <abstract language="deu">In dieser Bachelorarbeit wurde untersucht, wie körperliche Aktivität als adjuvante oder nicht-pharmakologische Therapie bei Depressionen eingesetzt werden kann. Es wurden sowohl die antidepressiven Effekte als auch potenzielle Wirkmechanismen analysiert. Der theoretische Teil beleuchtet Depressionen, neurobiologische Prozesse sowie gängige Behandlungsansätze. &#13;
Die Ergebnisse einer systematischen Literaturrecherche zeigen, dass körperliche Aktivität positive Effekte auf depressive Symptome, die maximale Sauerstoffaufnahme (VO2) und die Schlafqualität hat. Insbesondere individuelle Programme sind wirksam. &#13;
Es wurden die Vor- und Nachteile der Sporttherapie erörtert, sowie Empfehlungen für zukünftige Forschung gegeben.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-20348</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <licence>CC BY-SA 4.0 International - Namensnennung-Weitergabe unter gleichen Bedingungen</licence>
    <author>Trong Khang Tommy Vu</author>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Sport</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Depression</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Antidepressiva</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Effekte</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Bewegung</value>
    </subject>
    <collection role="ddc" number="57">Biowissenschaften; Biologie</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/2034/Bachelorarbeit_29192_Unterschrift.pdf</file>
  </doc>
  <doc>
    <id>888</id>
    <completedYear/>
    <publishedYear>2021</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2021-08-01</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2021-06-25</thesisDateAccepted>
    <title language="eng">The influence of zinc sulfate in the fermentation rate of cider under homebrewing conditions</title>
    <abstract language="eng">OBJECTIVE: The purpose of this study was to first determine the effectiveness of zinc sulfate at concentrations of 0.5 and 1 PPM (Parts Per Million) on the fermentation rate of yeast when brewing cider under homebrewing conditions and to compare it to commercial yeast nutrient. Zinc is an essential mineral for the production of alcohol as it is a co-factor in alcohol dehydrogenase, the enzyme responsible for alcohol production in yeast. The general consensus of zinc levels needed for yeast fermentation is 0.4 – 1.07 PPM (Nicola and Walker, 2011).&#13;
&#13;
METHODS: Data was collected using a refractometer of the brews. There were five brews in total, one with yeast nutrient, two with zinc sulfate at 0.5 PPM and two at 1PPM along with their controls.&#13;
&#13;
RESULTS: A total of 25 brews, in five groups of five, were performed. The results showed that supplementing the yeast with commercial yeast nutrient significantly improved the fermentation rate, while zinc sulfate at 0.5 and 1PPM showed no significant difference when compared to the controls.&#13;
&#13;
CONCLUSIONS: While a certain level of zinc is needed for fermentation, this study did not find supplementing homebrew cider with zinc sulfate to significantly improve the fermentation rate in comparison with control brews. When compared to yeast nutrient, zinc sulfate was not found to improve the fermentation rate. In order to consider whether or not supplementing zinc can improve fermentation in homebrewing, more studies must be conducted with different factors taken into consideration such as the yeast variant, the juice used and the initial concentration of zinc compounds in the juice.</abstract>
    <enrichment key="opus.source">publish</enrichment>
    <licence>CC BY-SA 4.0 International - Namensnennung-Weitergabe unter gleichen Bedingungen</licence>
    <author>Anh Tho Tran Nguyen</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
  </doc>
  <doc>
    <id>1271</id>
    <completedYear/>
    <publishedYear>2021</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>74</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-01-09</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2021-12-06</thesisDateAccepted>
    <title language="eng">Method development for quantification of prescription drugs Fluphenazine and Flupentixol in serum.</title>
    <abstract language="eng">The LVR clinic in Viersen belongs to a group of nine psychiatric clinics in NRW, Germany. In the pharmacy laboratory, the therapeutic drug monitoring is offered for antiepileptic drugs (AED´s), neuroleptics and antidepressants. Fluphenazine and Flupentixol are used to relieve the symptoms of schizophrenia and other similar mental health problems. The purpose of this work is the development and validation of methods for quantitation of the neuroleptics Fluphenazine and Flupentixol, contained in human serum. Therapeutic drug monitoring (TDM) is very important for a patient-matched therapy. TDM is applied to handle and direct the pharmacotherapy because of  the pharmacokinetic differences between different individuals. The developed methods should be afterwards introduced into the daily routine of the laboratory. The analytical device used for this purpose is a Liquid Chromatography with a Mass Spectrometer (LCMS), with a Biphenyl Accucore separation column which is also used for other neuroleptics quantised. For Fluphenazine, an already existing in the laboratory sample precipitation method was used. Also, an already applied for other similar neuroleptics LCMS method, called “Biphenyl03_new” (lasting for 11 minutes, with a high gradient between the elution agents) was taken on, and resulted in a good linearity. In case of Flupentixol, a completely new method had to be established, in order to achieve a baseline separation of cis-Z-Flupentixol and trans-E-Flupentixol. For the sample preparation, a solid phase extraction method was developed. The established methods were then applied for quantitation of patient samples, and the stability of the measurements was proved. Also, the accuracy and precision of obtained results was tested in the Proficiency Test. Limit of quantitation achieved for Fluphenazine was 0,5ng/ml, whereas for Flupentixol the LOQ was 0,25ng/ml. The Limit of detection found was 0,05ng/ml for both substances. The development was successful for both analytes and the established methods were integrated into the daily routine of the laboratory.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-12715</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Agata Torzewska</author>
    <collection role="ddc" number="61">Medizin und Gesundheit</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1271/Torzewska_Agata_Bachelorthesis.pdf</file>
  </doc>
  <doc>
    <id>2098</id>
    <completedYear/>
    <publishedYear>2024</publishedYear>
    <thesisYearAccepted/>
    <language>deu</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume/>
    <type>masterthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2024-11-27</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2024-10-07</thesisDateAccepted>
    <title language="deu">Die Rolle individueller Copingstrategien und Resilienz für die mentale Gesundheit im Kontext der Wahrnehmung der Klimakrise: Eine systematische Untersuchung empirischer Studien</title>
    <abstract language="deu">Hintergrund: Der Klimawandel ist ein globales Problem, welches bereits weltweit spürbar ist und sich zukünftig weiter verschärfen wird. Neben den damit einhergehenden physischen Auswirkungen für die Gesundheit, steigt auch die Relevanz mentaler Belastungen. Nicht nur das Erleben von Naturkatastrophen und extremen Wetterereignissen, sondern auch die Wahrnehmungen der Veränderungen wirkt bedrohlich und kann eine mentale Belastung für Menschen darstellen. Ziel der Masterarbeit war es zu untersuchen, welche Rolle individuelle Copingstrategien und Resilienz für die mentale Gesundheit und das Wohlbefinden im Kontext der Wahrnehmung der Klimakrise haben. Wesentlich war daher die Identifikation potenzieller Schutz- und Risikofaktoren sowie die Untersuchung von Copingstrategien im Kontext des Klimawandels, um gezielte Empfehlungen zur Stärkung der Resilienz und Verbesserung des psychischen Wohlbefindens abzuleiten.&#13;
&#13;
Methoden: Eine systematische Literaturrecherche wurde durchgeführt, um relevante, empirische Studien zu identifizieren. Das methodische Vorgehen orientierte sich an den Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Die Suche erfolgte auf den Datenbanken Web of Science, ScienceDirect, PubPsych, PubMed und PsycArticles. Zur Bewertung der methodischen Qualität und Bewertung des Verzerrungspotenzials der eingeschlossenen Studien, wurden die Critical Appraisal Checklisten des Joanna Briggs Instituts (JBI) verwendet. Die Ergebnisse der Studien wurden anhand zweier Evidenztabellen nach Studiendesign und Studienergebnissen synthetisiert und narrativ beschrieben.&#13;
&#13;
Ergebnisse: Insgesamt erfüllten 19 von 1.676 geprüften Studien die Einschlusskriterien. Die Studien untersuchten unterschiedliche Copingstrategien und -stile, wie Verhaltensweisen des umweltfreundlichen Handelns sowie problem-, emotions- und bedeutungsorientierte Bewältigungsstrategien. Verschiedene Faktoren wurden berücksichtigt, darunter emotionale Reaktionen, psychologische, soziale und kognitive Aspekte sowie soziodemografische Eigenschaften. Zunächst wurde untersucht, wie Copingstrategien in Verbindung mit den einbezogenen Faktoren stehen. Darauf aufbauend wurde analysiert, wie diese Copingstrategien die mentale Gesundheit beeinflussen und ob die Faktoren im Kontext des Klimawandels als Schutz- oder Risikofaktoren wirken. Beispielsweise zeigten leichte Ausprägungen der Angst vor dem Klimawandel sowohl aktivierende Effekte, in Form von umweltfreundlichen Verhaltensweisen, als auch die Neigung zu mentalen Beeinträchtigungen, bei starker Ausprägung. Sorgen zeigten im Studienvergleich gemischte Auswirkungen, indem sie teilweise problemorientiertes Coping begünstigten, teilweise jedoch auch belastend wirkten. Wut zeigte vorwiegend aktivierende Effekte und weniger Beeinträchtigungen für die mentale Gesundheit. Naturverbundenheit, Geschlecht und Alter standen oftmals mit problemorientiertem Coping in Verbindung, jedoch gleichzeitig mit einer erhöhten Anfälligkeit für mentale Beeinträchtigung. Daneben wurden zwei Studien identifiziert, die unterschiedliche Maßnahmen zur Reduktion der mentalen Belastungen durch den Klimawandel evaluierten und bei relevanten Parametern der mentalen Gesundheit positive Ergebnisse erzielten.&#13;
&#13;
Schlussfolgerung: Es besteht verstärkter Forschungsbedarf, um die mentalen Auswirkungen im Kontext der Wahrnehmung des Klimawandels besser zu verstehen und wirksame Maßnahmen zur Förderung der mentalen Gesundheit zu entwickeln. Ein einheitliches Verständnis der untersuchten Konstrukte ist dabei entscheidend, um eine Vergleichbarkeit zwischen den Studien zu gewährleisten und gesicherte Erkenntnisse zu gewinnen. Damit kann die Entwicklung zielgerichteter Maßnahmen und die Förderung von persönlichen Ressourcen sowie adaptives Coping im Zusammenhang mit der Klimakrise unterstützt werden.</abstract>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Zöbel Teresa</author>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Klimawandel</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Klimaangst</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Coping</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Resilienz</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Mentale Gesundheit</value>
    </subject>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
  </doc>
  <doc>
    <id>1597</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>deu</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>87</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-09-28</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="deu">Cannabislegalisierung in Deutschland: Auswirkungen auf den Jugend- und Gesundheitsschutz</title>
    <abstract language="deu">Das Thema der Cannabislegalisierung in Deutschland ist mit dem Beschluss im Koalitionsvertrag der neuen Koalition von 2021 so aktuell wie nie zuvor. In der vorliegenden Arbeit soll herausgearbeitet werden, ob die Cannabislegalisierung in Deutschland den Jugend- und Gesundheitsschutz fördern kann. Nach Beantwortung dieser Frage soll darüber hinaus analysiert werden, welche Maßnahmen bzw. Rahmenbedingungen der Legalisierung den Jugend- und Gesundheitsschutz am effektivsten fördern können. Zur Beantwortung dieser Forschungsfragen wurde eine umfassende Literaturrecherche durchgeführt.&#13;
Dass Cannabis in Deutschland trotz Verbot konsumiert wird, zeigt die Lebenszeitprävalenz von über 28 %. Es wurde herausgestellt, dass Cannabis insbesondere für Jugendliche gesundheitliche Gefahren mit sich bringt. Auf Grund der Illegalität wird das Cannabis unkontrolliert auf dem Schwarzmarkt verkauft, weshalb es oftmals zu minderwertiger Qualität oder sogar Streckmitteln und Verunreinigungen kommt, die zusätzliche Gesundheitsrisiken bergen. Ebenfalls wird der Kontakt zu anderen illegalen Drogen gefördert. &#13;
Staaten, die Cannabis bereits legalisiert haben, zeigen, dass der Konsum kaum anstieg und bei Jugendlichen sogar rückläufig war. Bezüglich cannabisinduzierter Krankheiten konnte ein Anstieg festgestellt werden, der allerdings auf die steigende gesellschaftliche Akzeptanz von Cannabis zurückzuführen ist. &#13;
Erstere Forschungsfrage lässt sich demnach damit beantworten, dass mit dem Wegfallen versteckter Gefahren des Schwarzmarktes der Jugend- und Gesundheitsschutz gefördert werden kann, da das alleinige Verbot nicht vom Konsum abhält. Mit gewissen Rahmenbedingungen, wie z.B. dem Preis, Verkaufsstellen, Höchstabgabemengen, Produktion und THC-Obergrenzen kann die Gesundheit der Konsumenten geschützt sowie auch die Häufigkeit und Intensität des Konsums eingeschränkt werden. Somit schützt die Legalisierung von Cannabis unter den richtigen Rahmenbedingungen effektiv die Gesundheit von Jugendlichen sowie allen Cannabiskonsumenten, während darüber hinaus finanzielle Vorteile entstehen.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-15970</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Daniel Sternberg</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1597/Sternberg_CannabislegalisierungDeutschland.pdf</file>
  </doc>
  <doc>
    <id>463</id>
    <completedYear/>
    <publishedYear>2020</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>64</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2020-06-02</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2020-05-19</thesisDateAccepted>
    <title language="eng">Optimization of RT-PCR Assays for the Roche cobas® 6800/8800 Utility Channel: Influence of 2´-O-Methyl modified Primers on PCR efficiency</title>
    <abstract language="eng">Automated, high-throughput real-time PCR instruments such as the cobas® 6800/8800 from Roche have revolutionized the operation in molecular diagnostics laboratories as they provide a complete process of patient samples including all necessary steps for PCR applications from material preparation up to the calculation and evaluation of final results with a minimum of user interaction.&#13;
In addition to the broad spectrum of commercially available ready-to-use reagent kits for blood screenings, virologic and microbiological assays as well as tests designed for women’s health, the cobas® 6800/8800 provides a tool which allows users to develop and implement their own tests onto the high-throughput device. Equipped with this tool, called the cobas® omni Utility Channel, these automated instruments serve a high flexibility and can be adjusted to users’ personal needs.&#13;
Notwithstanding the advantages of the Utility Channel, a limited number of lab developed tests have been implemented onto the cobas® 6800/8800 so far as no guideline for the optimization and transfer of such tests onto the Utility Channel has been provided to the public yet.&#13;
In the course of this bachelor thesis, four real-time PCR assays, including an allele-specific duplex test for HLA-B27, an established in-house test for the differentiation and detection of Ureaplasma urealyticum/parvum, a published assay for the detection of Chlamydia trachomatis as well as a duplex reverse-transcription assay for the detection and differentiation of norovirus genogroup one and two have been optimized for the use on Utility Channel. &#13;
Furthermore, 2´-O-Methyl modified primers have been integrated into the optimization process of all assays to asses their influence on PCR efficiency. &#13;
Three of these four assays have been transferred successfully onto a cobas® 6800 following a developed method which lead to the final design of a flowchart guideline for the optimization of lab developed tests for the use on a cobas® 6800/8800 system.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-4632</identifier>
    <licence>CC BY-ND 4.0 International - Namensnennung-Keine Bearbeitungen</licence>
    <author>Lukas Schiffers</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>PCR efficiency</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Modified primers</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Methylated primers</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Cobas</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Molecular biology</value>
    </subject>
    <collection role="ddc" number="57">Biowissenschaften; Biologie</collection>
    <collection role="ddc" number="61">Medizin und Gesundheit</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/463/Schiffers_Lukas_Bachelorarbeit.pdf</file>
  </doc>
  <doc>
    <id>1523</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>44</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-06-13</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2022-03-11</thesisDateAccepted>
    <title language="eng">Contribution of relocated biology technologies and mobile health for the estimation of cardiovascular risks.</title>
    <abstract language="eng">Cardiovascular diseases (CVDs) are the first mortality causes in the world (Khan 2021) and one of the main causes of death in Belgium. It is gauged that 17.9 million lives are taken every year worldwide. They are the causes of multiple issues, such as premature death or disabilities. They are as well causing a consequent impact on socio-economic aspects.&#13;
One of the cardiovascular risks, which is one of the main thematic of this thesis is Atrial Fibrillation (AF). AF is not a new pathology, it was already described in 1827 by Robert Adams, and then in the 20th century, William Einthoven, by inventing electrocardiography, enabled the first record of it (Staerk, Sherer, Ko et al. ,year 2017). AF is a type of cardiac arrhythmia, and the most sustained one. In Belgium it is estimated that 150 000 persons are affected by it. Being an important factor in the prevention of Heart Failures (HF) and Cardiovascular risks, the management, and the screening of it are a predominant matter taking in consideration the risks brought by it. Different protocols are established in hospitals, however it is a bit more limited in general practitioner’s offices (GP practices). The introduction to digital health devices can as well be delicate, as many benefits they can offer, a few disadvantages have to be taken into account in order to include them to a proper protocol. Establishing a protocol including different factors such as relocated biology technologies and mobile health, while being external to the GP practices, can prove itself to be a challenge.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-15232</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY-ND 4.0 International - Namensnennung-Keine Bearbeitungen</licence>
    <author>Anne-Victoria Roehrich</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Cardiology</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Biotechnologies</value>
    </subject>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1523/Roehrich_bachelorthesis.pdf</file>
  </doc>
  <doc>
    <id>2115</id>
    <completedYear/>
    <publishedYear>2024</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>55</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2024-11-27</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">A Systematic Review of Rapamycin- Mediated Fetal Hemoglobin Induction via the mTOR Pathway</title>
    <abstract language="eng">mTOR inhibitor rapamycin has been observed to induce fetal hemoglobin in patients of β-hemoglobinopathies, a group of disorders in which mutations in the gene responsible β-globin chains results in reduced or malformed RBC production, leading to anemia. The induction of fetal hemoglobin bypasses these mutations, as they are found on the gene responsible for adult hemoglobin. Following birth, the fetal hemoglobin gene is silenced, and the adult gene is activated through a process known as the hemoglobin switch. Rapamycin treatment reverses this hemoglobin switch but the mechanism by which it does so is currently unknown. Rapamycin functions through its inhibition of mTORC1, a protein complex responsible for nutrient- and growth factor-dependent cell growth and proliferation. This literature review seeks to collate existing information on the mTORC1 signalling pathway and the hemoglobin switch, allowing for a specific mechanism by which rapamycin induces fetal hemoglobin through its inhibition of mTORC1 to be hypothesized. Following the literature search, 55 studies on the mTORC1 pathway and 31 studies on the hemoglobin switch were summarized. Using the information gained from this, three hypotheses were put forward for the possible induction mechanism, out of which the primary hypothesis is based on the hemoglobin switching factor KLF1. This was based on the observation that the knockdown of Raptor, a crucial component of mTORC1, in mice caused a decreased expression of KLF1. As KLF1 is an essential component of the hemoglobin switch, this provides a direct link between the inhibition of mTORC1 and the reversal of the hemoglobin switch. Additionally, the efficiency of rapamycin in comparison to other methods of fetal hemoglobin was discussed, including newer generations of mTOR inhibitors developed using rapamycin as a foundation. Finally, possible avenues of research to confirm the validity of the proposed hypotheses and to address points of ignorance within each topic were discussed.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-21155</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY 4.0 International - Namensnennung</licence>
    <author>Hasiru Ratnayake</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/2115/ratnayakerapamycin.pdf</file>
  </doc>
  <doc>
    <id>490</id>
    <completedYear/>
    <publishedYear>2020</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>65</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2020-06-30</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2020-06-02</thesisDateAccepted>
    <title language="eng">Evaluation of two methods to reduce legume-related flatulence through enzymatic digestion of flatulence factors</title>
    <abstract language="eng">Legumes are nutritionally equivalent to many meat products, and can be used to supplement or replace meat in daily diets. This is beneficial for a variety of reasons, such as: i) growing legumes can help to reduce acidification of soil, global warming potential and energy  use; ii) livestock is taxing on the environment in terms of adding to the volume of greenhouse gases and nitrification of soil while legume crops fix soil nitrogen. &#13;
&#13;
Consumers can be opposed to adding legumes to their diet due to the perception of legumes causing flatulence. Intestinal gas buildup, bloating, cramps, abdominal pain and flatulence are caused by raffinose family oligosaccharides (RFOs) which cannot be digested in monogastric organisms such as humans. They are therefore broken down by microflora in the intestine; this bacterial digestion releases large volumes of hydrogen, which causes flatulence. &#13;
&#13;
The human body lacks the enzyme required to break down these RFOs — ⍺-galactosidase. This experiment evaluated two methods of applying ⍺-galactosidase to RFOs before they reach the intestinal microflora. The first method evaluates the effectiveness of enzymatically digesting the legumes before consumption. The second evaluates the effectiveness of the enzyme supplement Beano, which applies the enzyme to RFOs in the stomach. &#13;
&#13;
Experimental data showed that enzymatically digesting raw flours does significantly reduce the amount of RFOs in the legume. Similarly, Beano also reduces RFOs significantly. In 4 out of the 6 legumes sampled, there was no significant difference between the two methods. &#13;
&#13;
In order to consider the methods for commercial use, other factors (such as economic, logistical, etc.) must also be considered. At the outset, it appears that taking an enzyme supplement such as Beano might be more economically viable in the long term for the consumer, since processing costs for the flatulence free legumes would drive up the price of (normally cheap) legumes. &#13;
There is an increase in the amount of people who are giving up meat for environmental and other reasons. For these consumers, as well as those who come from cultures that integrate legumes in their cuisine, the removal of flatulence factors from this nutrition-rich food group will be very beneficial.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-4903</identifier>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Shraddha Ranganathan</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Alpha-galactosidase</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Bloating</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Enzymatic assay</value>
    </subject>
    <collection role="ddc" number="61">Medizin und Gesundheit</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/490/Ranganathan_Shraddha_Bachelor thesis.pdf</file>
  </doc>
  <doc>
    <id>1911</id>
    <completedYear/>
    <publishedYear>2024</publishedYear>
    <thesisYearAccepted/>
    <language>deu</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>75</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2024-03-12</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="deu">Der Effekt kurzkettiger Fettsäuren auf die Darmmikrobiota im Zusammenhang mit Adipositas</title>
    <abstract language="deu">Der demographische Wandel führt zu einer stetig höheren Lebenserwartung der Menschen. Ein erhöhtes Alter birgt das Risiko an einer Vielzahl von Krankheiten zu leiden. Darunter fallen insbesondere Herz Kreislauf¬ Erkrankung und Krebserkrankung. Solche Erkrankung fallen ebenfalls unter die Folge  und Begleiterkrankung einer Adipositas. Die Adipositas ist eine Stoffwechselerkrankung und beschreibt ein erhöhtes Körpergewicht aufgrund eines erhöhten Körperfettanteils. Die Erkrankung kann beispielsweise durch eine Ernährungsumstellung gelindert werden. Die Ernährung kann unter anderem auch die Darmmikrobiota modulieren. Insbesondere Ballaststoffe und die Fermentationsprodukte der Ballaststoffe, die kurzkettigen Fettsäuren, haben einen Einfluss auf die Darmmikrobiota. Aufgrund dessen werden in dieser Arbeit die Effekte der kurzkettigen Fettsäuren auf die Darmmikrobiota insbesondere im Zusammenhang mit der Erkrankung Adipositas untersucht. Die Ursachen einer Adipositas liegen meist in den Lebensweisen der Patienten. Eine erhöhte Energieaufnahme und geringe Bewegung führen zu einem Anstieg des Körperfettanteils und erhöhen zudem das Risiko für Begleiterkrankung, wie Diabetes mellitus Typ 2, koronaren Herzkrankheiten oder auch Depressionen. Insbesondere die konservativen Behandlungsmöglichkeiten zeigen wenig positive Ergebnisse und die Entwicklung neuer Methoden muss Priorität haben. Die Fermentationsprodukte der Ballaststoffe sind die kurzkettigen Fettsäuren. Diese haben sowohl orexigene als auch anorexigene Eigenschaften. Bei der Ausarbeitung der Ergebnisse wurde deutlich, dass die kurzkettigen Fettsäuren bei der Behandlung der Adipositas von großer Bedeutung sein können. Sie beeinflussen wichtige Rezeptoren, die die appetithemmende Hormone PYY und GLP 1 freisetzen und eine überschüssige Nahrungsaufnahme verhindern. Des Weiteren wirken sich die kurzkettigen Fettsäuren positiv auf die Gluconeogenese aus. Zudem konnten verschiedene Studien über Supplementierungen positive Effekte der kurzkettigen Fettsäuren verzeichnen. Dennoch ergaben sich bei der Bearbeitung der Literatur ebenfalls widersprüchliche Ergebnisse. Um die genauen Effekte der kurzkettigen Fettsäuren lückenfrei zu erschließen sind weitere Forschungen und Experimente zwingend notwendig. Die ersten Untersuchungen zeigen aber, dass eine ballaststoffreiche Ernährung und eine erhöhte Konzentration der kurzkettigen Fettsäuren bei der Behandlung und Prävention eine entscheidende Rolle annehmen.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-19117</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY 4.0 International - Namensnennung</licence>
    <author>Ann-Kathrin Pastoors</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1911/Pastoors_BA.pdf</file>
  </doc>
  <doc>
    <id>943</id>
    <completedYear/>
    <publishedYear>2021</publishedYear>
    <thesisYearAccepted/>
    <language>deu</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>69</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2021-10-26</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2021-09-29</thesisDateAccepted>
    <title language="deu">Cannabinoide in der analgetischen Therapie: Chancen und Risiken</title>
    <abstract language="deu">Hintergrund: In den letzten Jahren finden die Cannabinoide THC und CBD immer mehr Bedeutung in der Medizin zur Behandlung von Schmerzen. Die ärztliche Verordnung von medizinischem Cannabis ist seit 2017 in Deutschland legal. Viele Ärzte zögern bei Indikation der Patienten eine Verordnung aufgrund mangelnder Aufklärung hinaus. Auch in der Gesellschaft erfährt Cannabis eher negative Bewertungen bedingt durch seines Vorurteils zur Einstiegsdroge. Dabei bietet die Nutzung von Cannabis in der Medizin nicht nur Risiken, sondern auch Chancen in der Analgesie.&#13;
&#13;
Ziele: Ziel dieser Arbeit ist die Darstellung von Chancen und Risiken der Cannabinoide in der analgetischen Therapie.&#13;
Ergebnisse: Kombinationspräparate, die CBD und THC in einem 1:1 Verhältnis enthalten, weisen eine hohe Analgesie auf. CBD antagonisiert nachweislich die psychoaktive Komponente des THC. Auch gastrointestinale Nebenwirkungen wie Obstipation, Nausea und Emesis lassen sich durch die richtige Dosis lindern. Als adjuvante Therapieform können Cannabinoide die Menge der einnehmenden Opioide bei langfristigen Therapien senken. Wird THC in zu hoher Dosis und ohne ärztliche Betreuung eingenommen, kann die Psychoaktivität steigen und es treten unerwünschte Nebenwirkungen wie Angststörungen, Schlafstörungen oder Depressionen auf.&#13;
&#13;
Fazit: Die Chancen der Cannabinoide liegen primär in der Analgesie. Auch Nebenwirkungen ausgelöst durch andere Erkrankungen oder Arzneimittel lassen sich lindern. Unter ärztlicher Betreuung können Nebenwirkungen präventiv vermieden werden, indem das Präparat, die Dosis und die Applikationsform individuell auf den Patienten abgestimmt werde</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-9430</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <licence>Bestimmungen des deutschen Urheberrechts</licence>
    <author>Anna-Marie Niederholz</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/943/Niederholz_Anna_Marie_Bachelorarbeit.pdf</file>
  </doc>
  <doc>
    <id>1510</id>
    <completedYear/>
    <publishedYear>2021</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>91</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-05-30</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">Oral Enzyme Therapy in Systemic Analgetic Treatment</title>
    <abstract language="eng">The possibility of an oral enzyme combination being able to replace diclofenac in the treatment of pain and inflammation is discussed. Oral enzyme therapy involves the use of proteolytic enzymes like bromelain, serratiopeptidase, trypsin, rutin, and papain. The goal of oral enzyme therapy is to replace non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of symptoms requiring short or long-term treatment due to the side effects of NSAIDs for example diclofenac. The main analysis is focused on the analgesic and anti-inflammatory effects of oral enzyme therapy.&#13;
The results are based on database retrieval covering single oral enzymes and oral enzyme combinations like Wobenzym and Phlogenzym. Osteoarthritis and post- surgery treatment studies of oral enzyme therapy are included to analyze the efficacy and effectiveness of the new treatment approach. Bromelain, serratiopeptidase, and rutin are covered in their industrial production. Safety and efficacy, trial diversity, economics, and the potential of oral enzymes being the new homeopathy are discussed.&#13;
Oral enzymes show a great safety profile in the overall comparison to NSAIDs with tolerability rated as good and very good by patients and physicians. The trial diversity has an impact on the comparability resulting in the need for a cohesion set-up for the retrieval of evidence on the efficacy and effectiveness of oral enzyme therapy. The economic situation of oral enzymes is defined by the currently expensive production of enzymes with a possible reduction in retail price due to new techniques and technology. With the presence of new studies of high quality in the future, a detailed revision of facts is advised on oral enzymes being an alternative to NSAIDs.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-15107</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Lisa-Camilla Mutzberg</author>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Oral enzyme therapy</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>NSAIDs</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Proteolytic enzymes</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Diclofenac</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Osteoarthritis</value>
    </subject>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1510/Lisa-Camilla_Mutzberg_25093.pdf</file>
  </doc>
  <doc>
    <id>1856</id>
    <completedYear/>
    <publishedYear>2023</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>70</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2023-12-26</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2023-10-27</thesisDateAccepted>
    <title language="eng">Generation and expression of a mutated murine tRNA-guanine transglycosylase variant</title>
    <abstract language="eng">Translation of messenger RNA carrying the nucleic code for protein synthesis is one of the vital bioprocesses of living organisms. This translation is mediated by transfer RNA, which allocates specific amino acids to the growing chain by decoding the genetic code. The tRNAs with the G34U35N36 anticodon sequence are recognised by an enzyme called tRNA-guanine transglycosylase, which catalyses the exchange of guanine with queuine. TGT enzyme is found in all three domains of life and is involved in post-transcriptional modification. TGT is of keen interest in the development of therapeutics against shigellosis, since the genetic inactivation of TGT leads to decreased pathogenicity in Shigella. For understanding the differences between bacterial and eukaryotic TGT, studies have been performed in the past, which show remarkable resemblance. On the contrary, some pronounced structural contrast can also be observed. One prominent difference is that the bacterial TGT contains a short turn of three amino acids, whereas, in eukaryotes, this turn is replaced by an extended loop of more than 45 amino acids. The function of this loop in eukaryotic TGT is not known. The loop is a highly flexible region and, thus, is not structurally solved. To elucidate the function of this loop, a TGT mutant lacking this loop was generated, expressed and purified. TGT mutant was expressed in different bacterial cell strains. For the purification, different chromatography techniques were utilised. The mutation resulted in a low yield of the protein in comparison to the wild-type TGT. This leads to the inference that the loop influences the physicochemical characteristics of the protein.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-18560</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <licence>CC BY-NC 4.0 International - Namensnennung-Nicht kommerziell</licence>
    <author>Muhammad Imran Mumtaz</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>RNA-guanine transglycosylase</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Generation</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Expression</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Queuine</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Protein purification</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Chromatography</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Site-directed mutagenesis</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Protein mutation</value>
    </subject>
    <collection role="ddc" number="57">Biowissenschaften; Biologie</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1856/Mumtaz_MurineQTRT2.pdf</file>
  </doc>
  <doc>
    <id>1944</id>
    <completedYear/>
    <publishedYear>2024</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>78</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2024-05-06</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2024-04-08</thesisDateAccepted>
    <title language="eng">Efficacy of Traditional Chinese Medical DrugsThe Treatment of Common Illnesses in Comparison with Western medicine</title>
    <abstract language="eng">The efficacy of treating common illnesses with traditional Chinese medical drugs has been a subject of growing interest and debate especially when compared to established practices of modern &#13;
Western medicine. The integration of alternative and traditional medicine practices also gains significance as healthcare systems evolve. &#13;
This literature review aims to comprehensively assess and compare the effectiveness of traditional Chinese medical drugs with modern Western medial drugs in addressing common illnesses. Through a systematic analysis of reviewed scientific articles, clinical studies, and relevant literature the effectiveness of traditional Chinese medical drugs will be identified and compared to modern Western medical drugs and treatment options in context of the treatment success rates, symptom relief, adverse effects, and patient satisfaction.&#13;
The study focuses on the herbal based remedies and their traditional therapeutic treatment methods, to illuminate their mechanisms of action and potential therapeutic benefits for a range of common illnesses such as the common cold and flu, digestive disorders, musculoskeletal pain, and skin conditions. Furthermore, the potential synergies between the two practices will be explored, as integrative healthcare becomes increasingly important as a comprehensive approach to patient wellbeing.&#13;
Through a comprehensive analysis of the available medical literature and clinical data, this paper attempts to address the potential of traditional Chinese medical drugs as an alternative or complementary method to modern Western medicine for various common illnesses. The findings may contribute to informed decision-making by healthcare professionals and patients, offering insights into the strengths and limitations of each approach. Additionally, the research aims to foster a deeper understanding of cross-cultural medical practices and their potential integration into contemporary healthcare systems.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-19440</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Clarissa May</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Traditional Chinese medicine</value>
    </subject>
    <collection role="ddc" number="61">Medizin und Gesundheit</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1944/May_Clarissa_Bachelorarbeit.pdf</file>
  </doc>
  <doc>
    <id>1530</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>72</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-06-29</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2022-06-06</thesisDateAccepted>
    <title language="eng">Comparative analysis of guide RNA design tools</title>
    <abstract language="eng">Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR), has rapidly come to the forefront of genome engineering and has revolutionized the field. Today, CRISPR-Cas is regarded to be the most effective and efficient tool in genome editing. It is considered to have many applications in medicine, agriculture and biotechnology. The Cas protein and gRNA are two of the most crucial components of the CRISPR-Cas system. Currently, there are barriers that prevent the full potential of CRISPR-Cas systems in clinical applications, including, ethical concerns, off-target effects, immune system response, method of delivery. Off-target prevention relies heavily on gRNA analysis. With the help of technology and algorithms developed based on researches, there have been many bioinformatical tools focused on the off-target activity inhibition and increasing efficiency. In order to achieve practical use of CRISPR systems, there needs to be more predictive bioinformatical tools to minimize the off-target activity. This thesis aims to review some of these tools and discusses the criteria for future bioinformatical tools’ development by addressing the current limitations and challenges.&#13;
This thesis is written theoretically by using various reputable resources such as PubMed in English. Because many of the tools covered in this thesis had no prior reviews, the author had to learn how to use them, therefore this thesis does not cover all of their features for professional users.&#13;
In the result section, the author has provided figures from the interface of the tools along with description of the functionality of the algorithms in use. All of the mentioned tools are then examined in the discussion part. There, features such as speed, ease of use for beginners, price, being open-source, being web or local based, flexibility in working with other tools and batch analysis are reviewed and compared. There short conclusive results are also depicted in a table for effective comparison.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-15307</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY-NC-SA 4.0 International - Namensnennung-Nicht kommerziell-Weitergabe unter gleichen Bedingungen</licence>
    <author>Parsa Lavasanifar</author>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1530/Thesis.pdf</file>
  </doc>
  <doc>
    <id>442</id>
    <completedYear/>
    <publishedYear>2020</publishedYear>
    <thesisYearAccepted/>
    <language>deu</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>86</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2020-03-05</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2020-01-27</thesisDateAccepted>
    <title language="deu">Optimierung der Krebstherapie durch Inhibition von MDR1</title>
    <abstract language="deu">MDR1 (Multidrug Resistance Protein 1) stellt ein Membranprotein dar, welches das Ziel hat, den Körper vor Toxinen und Xenobiotika zu schützen. Dieser Schutzmechanismus kann sich allerdings erheblich auf die Chemotherapie auswirken, indem Wirkstoffe aus der Zielzelle heraustransportiert werden. Da der Effekt von MDR1 in einigen Fällen unerwünscht ist, kommt es zum Einsatz von Inhibitoren. Diese lassen sich je nach Toxizität und Herkunft in verschiedene Kategorien einteilen.&#13;
Diese Arbeit gibt zunächst einen wissenschaftlichen Hintergrund. Zuerst werden Multiwirkstoffresistenzen im allgemeinen beschrieben, bevor MDR1 genauer beleuchtet wird. Danach werden verschiedene Bereiche der Krebserkrankung erläutert, um im Anschluss die unterschiedlichen Klassen der Inhibitoren vorzustellen. Die Diskussion schildert schlussendlich sowohl Chancen als auch Risiken der Inhibition und setzt diese in ein Verhältnis.&#13;
Zusammenfassend lässt sich sagen, dass es in der Chemotherapie vermehrt zu Wirkstoffresistenzen kommt. Krebszellen adaptieren und ändern ihre Genexpression, sodass altbewährte Medikamente nicht mehr greifen. Die Inhibition könnte dies umkehren, bringt aber zusätzliche Nebenwirkungen mit sich, sodass sich keine klare Empfehlung zugunsten der Inhibition von MDR1 geben lässt.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-4427</identifier>
    <licence>CC BY 4.0 International - Namensnennung</licence>
    <author>Marian Klose</author>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Krebs</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>MDR1</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>P-Glykoprotein</value>
    </subject>
    <subject>
      <language>deu</language>
      <type>uncontrolled</type>
      <value>Optimierung</value>
    </subject>
    <collection role="ddc" number="57">Biowissenschaften; Biologie</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/442/Klose_Marian_Bachelorarbeit.pdf</file>
  </doc>
  <doc>
    <id>1537</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>92</pageNumber>
    <edition/>
    <issue/>
    <volume/>
    <type>bachelorthesis</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-07-03</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>2022-05-10</thesisDateAccepted>
    <title language="eng">3D bioprinting of cartilage tissue: Current advances and challenges in tissue engineering</title>
    <abstract language="eng">As industrial technologies develop, some techniques were adopted and applied in medical fields for treatment improvement. Among them, 3D bioprinting is regarded as a rising and trending technology in the tissue engineering area. This is because not only does it offer patients customized organs or tissues, but also it can lower animal test dependency on drug testing. This paper is mainly focused on the use of 3D printing as a cartilage tissue fabrication for transplantation. In the beginning, general information and background knowledge concerning cartilage and bioprinting approaches were addressed. Subsequently, current research results from eight research teams related to cartilage tissue printing and grafting were introduced. Then the reports were classified and sorted into several groups to analyze and evaluate various methods' properties, advantages, and disadvantages. After that, some classic and traditional ways to produce artificial tissues without 3D bioprinting techniques were described to prove the strength of the novel tissue engineering technology. In the end, several side points, such as limitations, 3D bioprinting usages in fields other than tissue transplantation, market value, and outlook of bioprinting, were discussed. Information and sources were retrieved using Google and PubMed database search engines under specific inclusion and exclusion criteria through a PCC concept. Although the 3D bioprinting technique is still in development processes, it has a high potential to be a game-changing approach in the medical and pharmaceutical fields after commercialization in the future.</abstract>
    <identifier type="urn">urn:nbn:de:hbz:1383-opus4-15373</identifier>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">true</enrichment>
    <licence>CC BY-NC-ND 4.0 International - Namensnennung-Nicht kommerziell-Keine Bearbeitungen</licence>
    <author>Wooyong Kim</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>3D bioprinting</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Cartilage</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Tissue transplantation</value>
    </subject>
    <collection role="ddc" number="50">Naturwissenschaften</collection>
    <collection role="ddc" number="61">Medizin und Gesundheit</collection>
    <collection role="institutes" number="">Fakultät Life Sciences</collection>
    <thesisPublisher>Hochschule Rhein-Waal</thesisPublisher>
    <thesisGrantor>Hochschule Rhein-Waal</thesisGrantor>
    <file>https://opus4.kobv.de/opus4-rhein-waal/files/1537/Kim_Wooyong_Bachelorthesis.pdf</file>
  </doc>
</export-example>
